Voltari Corp  

(Public, NASDAQ:VLTC)   Watch this stock  
Find more results for NASDAQ:MOTR
0.00 (0.00%)
Real-time:   11:21AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.05 - 2.20
52 week 2.05 - 8.60
Open 2.20
Vol / Avg. 10,582.00/54,934.00
Mkt cap 18.90M
P/E     -
Div/yield     -
EPS -1.19
Shares 8.99M
Beta -0.41
Inst. own 58%

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin -1243.10% -10263.27%
Operating margin -1191.38% -10242.86%
EBITD margin - -9675.51%
Return on average assets -45.91% -54.86%
Return on average equity - -
Employees 91 -
CDP Score - -


601 W 26th St Rm 415
NEW YORK, NY 10001-1116
United States - Map
+1-212-7929671 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Voltari Corporation is engaged in the business of acquiring, financing and leasing commercial real properties. The Company owns approximately one commercial real property in Long Branch, New Jersey, which it leases to JPMorgan Chase Bank, N.A. (Chase) pursuant to a triple net lease (the Long Branch Lease). The Company intends to acquire additional properties primarily in the Northeast United States. The Company intends to lease such properties pursuant to double net or triple net leases. The Company intends to explore additional strategic opportunities from time to time, which may include opportunities with respect to its intellectual property, investments in various industries or acquisitions. The Company's subsidiary is Voltari Real Estate Holding LLC.

Officers and directors

Peter K. Shea Chairperson of the Board
Age: 64
Bio & Compensation  - Reuters
Richard L Sadowsky Acting Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Andreea Paraschivoiu Chief Financial Officer
Age: 36
Bio & Compensation  - Reuters
Kenneth Goldmann Chief Administrative and Accounting Officer
Age: 68
Bio & Compensation  - Reuters
Jay A. Firestone Independent Director
Age: 58
Bio & Compensation  - Reuters
Kevin Lewis Independent Director
Age: 44
Bio & Compensation  - Reuters